FATTIZZO, BRUNO
FATTIZZO, BRUNO
Dipartimento di Oncologia ed Emato-Oncologia
Safety and Effectiveness of Sutimlimab in Cold Agglutinin Disease: A Real‐World International Experience
2026 B. Fattizzo, E. Sambruna, Y. Miyakawa, M. Michel, C. Visco, M. Fillitz, G. Kannourakis, M.B. Greve, M. Kleemiss, J. Cid, A. Patriarca, L. Pavan, A. Dizdari, N. Maschio, A. Sau, C. Bitetti, R.M. Colombo, L. Curreli, D. Lame, U. Markovic, F. Pappagallo, G.L. Pedone, D. Rapezzi, V. Sammartano, N. Tumedei, A.G. Solimando, J. Marit, L. Fianchi, J. Khwaja, A. De Vivo, F. Lanza, F. Vianello, E.N. Oliva, C. Broome, F. Passamonti, U. Jaeger, B. Jilma, G. Moulis, W. Barcellini
Mixed Type Autoimmune Hemolytic Anemia: Clinical Severity and Treatment Patterns in a Large Observational Study
2026 F. Versino, U. Markovic, G.L. Pedone, S. Pergolizzi, F. Passamonti, W. Barcellini, A. Romano, B. Fattizzo
Thrombophilia screening in patients with autoimmune hemolytic anemia: a single-center analysis
2026 B. Fattizzo, M. Abbatista, N. Cecchi, C. Novembrino, M. Boscolo-Anzoletti, G.L. Pedone, M. Bortolotti, A. Artoni, J.A. Giannotta, F. Peyvandi, F. Passamonti, W. Barcellini, M. Capecchi
Case Report: Refractory cold agglutinin disease with hypersplenism: efficacy of splenectomy in a patient treated with sutimlimab
2026 A. Sau, D. Onofrillo, A.C. Russo, G. Di Prinzio, A.M. Quaglietta, M. Di Ianni, B. Fattizzo
Sutimlimab vs B-Cell-Targeted Therapy in Cold Agglutinin Disease: Which Is the Optimal Approach?
2026 B. Fattizzo, Y. Miyakawa, C. Broome
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapy
2026 W. Barcellini, B. Fattizzo
Predicting the differential diagnosis of inherited versus acquired bone marrow failure syndromes: Development of simple clinical scoring systems
2026 M. Bortolotti, B. Fattizzo, S. Stella, J. Jiang, F. Versino, C. Engelbrecht, R. Trikha, J. Large, S. Gandhi, K. Snape, D. Consonni, F. Passamonti, W. Barcellini, A.G. Kulasekararaj
Severe aplastic anemia secondary to immune checkpoint inhibitor: case report and literature review
2025 A. Bosi, M.C. Di Chio, M. Bortolotti, G.A. Croci, F. Passamonti, W. Barcellini, B. Fattizzo
A Case of Hodgkin Lymphoma in a Gaucher Disease Patient: Distinguishing Gaucher and Pseudo-Gaucher Cells
2025 N. Scaramellini, M. Canzi, E. Cassinerio, M. Migone De Amicis, L. Pettine, B. Fattizzo, F.G. Rossi, G. Croci, I. Motta
Not-so-rare defects of RBC lipidic composition: four new cases of flippase deficiency due to ATP11C mutations
2025 E. Fermo, E. Trombetta, A.P. Marcello, C. Vercellati, G.M. Ferrari, A. Zaninoni, V. Brancaleoni, E. Di Pierro, S. Beneventi, M. Tornese, B. Fattizzo, T. Casini, P. Corti, P. Bianchi
Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study.
2025 B. Fattizzo, A. Marchetti, A. Bosi, C. Gurnari, J. Giannotta, G. Pedone, E. Rossi, V. Carrai, A. Guido, F. Brioschi, M. Carpenedo, M. Crugnola, D. Caramazza, L. Leuzzi, M. Marchetti, G. Merati, S. Malato, F. Vianello, A. Patriarca, H. Awada, M. Bortolotti, M. Canzi, N. Bolli, M. Capecchi, F. Chen, A. Artoni, J. Maciejewski, W. Barcellini
Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes
2025 N. Galli, L. Pettine, G. Croci, F. Passamonti, W. Barcellini, B. Fattizzo
Unmet Needs and Their Impact on Quality of Life and Symptoms in Myelodysplastic Neoplasm Patients and Caregivers
2025 E. Crisà, D. Cilloni, M. Riva, E. Balleari, D. Barraco, B. Manghisi, L. Borin, M. Calmasini, A. Calvisi, I. Capodanno, M.G. Della Porta, E. Diral, B. Fattizzo, S. Fenu, S. Paolini, C. Finelli, C. Fozza, C. Frairia, V. Giai, M. Turrini, M.A. Isoni, F. Itri, L. Maurillo, A. Molteni, G.A. Palumbo, A.M. Pelizzari, F. Pilo, A. Poloni, C. Bosi, G. Sanpaolo, R. Sancetta, C. Amato, V. Santini, M.T. Voso, S. Salek, T. Ionova, A. Nosari, E.N. Oliva
Bone marrow microenvironment in autoimmune hemolytic anemia: from trephine biopsy to single cell RNA sequencing
2025 B. Fattizzo, M.C. Da Via, F. Lazzaroni, A. Marchetti, A. Marella, A. Maeda, A.G. Solimando, L. Pettine, F. Passamonti, N. Bolli, W. Barcellini
Real‐world evidence of pegcetacoplan in patients with paroxysmal nocturnal haemoglobinuria: A nationwide Italian study
2025 E. Metafuni, F.A. Brioschi, A. Patriarca, C. Leoni, G. Battipaglia, D. Carlino, A. Condorelli, V. Di Giacomo, S. Marktel, M.A. Marzilli, M. Miglino, E.N. Oliva, A. Sau, A. Ricco, G. Sanpaolo, A. Trolese, A.P. Iori, S. Sica, W. Barcellini, B. Fattizzo
Breakthrough hemolysis in paroxysmal nocturnal hemoglobinuria throughout clinical trials: from definition to clinical practice
2025 B. Fattizzo, F. Versino, W. Barcellini
Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World
2025 B. Fattizzo, C. Gurnari, S. Giammarco, A. Ricchiuti, H. Awada, M. Bortolotti, N. Galli, G.L. Pedone, F. Versino, D. Consonni, R. Trikha, S. Gandhi, S. Sica, J.P. Maciejewski, A. Kulasekararaj, W. Barcellini
Response to luspatercept can be predicted and improves overall survival in the real‐life treatment of LR‐MDS
2025 A. Consagra, L. Lanino, N.H. Al Ali, L. Aguirre, Z. Xie, O. Chan, G. Andreossi, M.G. Raddi, L. Rigodanza, A. Sanna, G. Mattiuz, E. Tofacchi, C. Amato, M. Tanturli, S. De Pourcq, A. Walker, A. Kuykendall, J. Lancet, E. Padron, D.A. Sallman, F. Restuccia, A. Perego, M. Ubezio, B. Fattizzo, M. Riva, G. Maggioni, A. Campagna, M.G. Della Porta, V. Santini, R.S. Komrokji
Characterization of Breakthrough Hemolysis in Patients With Paroxysmal Nocturnal Hemoglobinuria: An International Multicenter Experience
2025 B. Fattizzo, G.L. Pedone, E. Metafuni, E. Beggiato, V. Giai, E. Natalie Oliva, A. Ricchiuti, M. Bortolotti, S. Raso, D. Carlino, M. Memoli, S. Vecchi, J. Vidler, S. Gogoi, S. Goel, A. Corby, R. Trikha, S. Balakrishnan, F. Passamonti, A. Paola Iori, S. Sica, S. Gandhi, W. Barcellini, A. Kulasekararaj
Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization
2024 F. Versino, N. Revelli, S. Villa, L. Pettine, A. Zaninoni, D. Prati, F. Passamonti, W. Barcellini, B. Fattizzo